WTW has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
WTW has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Willis Towers Watson's accounts receivables for the quarter that ended in Dec. 2023 was $1,581 Mil.
Accounts receivable can be measured by Days Sales Outstanding. Willis Towers Watson's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 49.51.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Willis Towers Watson's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-165.40.
The historical data trend for Willis Towers Watson's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Willis Towers Watson Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accounts Receivable | Get a 7-Day Free Trial | 1,831.00 | 1,589.00 | 1,504.00 | 1,464.00 | 1,581.00 |
Willis Towers Watson Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Accounts Receivable | Get a 7-Day Free Trial | 1,464.00 | 1,412.00 | 1,408.00 | 1,296.00 | 1,581.00 |
Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Willis Towers Watson's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 1581 | / | 2914 | * | 91 |
= | 49.51 |
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Willis Towers Watson's accounts receivable are only considered to be worth 75% of book value:
Willis Towers Watson's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:
Net-Net Working Capital Per Share | |||||||
= | (Cash And Cash Equivalents | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (1424 | + | 0.75 * 1581 | + | 0.5 * 0 | - | 19497 |
- | 0 | - | 73) | / | 102.538 | ||
= | -165.40 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Thank you for viewing the detailed overview of Willis Towers Watson's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
Pamela Thomson-hall | officer: Head of International | 51 LIME STREET, LONDON X0 EC3M 7DQ |
Anne Pullum | officer: Head of Strategy and CAO | C/O WILLIS TOWERS WATSON, 200 LIBERTY ST, 7TH FLOOR, NEW YORK NY 10281 |
Julie Jarecke Gebauer | officer: Head of Human Capital&Benefits | JUPITER SATURN HOLDING CO, 875 THIRD AVENUE, NEW YORK NY 10022 |
Fredric J Tomczyk | director | TORONTO DOMINION CENTRE, PO BOX 1, TORONTO A6 M5K IA2 |
Stephen M. Chipman | director | 3101 DREXEL DRIVE, DALLAS TX 75205 |
Jacqueline Hunt | director | 53 SOUTH GREEN, MATTISHALL, NORFOLK X0 N220 3JY |
Anne Donovan Bodnar | officer: Head of Human Resources | 901 N. GLEBE ROAD, ARLINGTON VA 22203 |
Gene H Wickes | officer: Head of Exchange Solutions | 901 N GLEBE ROAD, ARLINGTON VA 22203 |
Brendan R Oneill | director | C/O IMPERIAL CHEMICAL INDUSTRIES PLC, 20 MANCHESTER SQUARE, LONDON X0 W1U 3AN |
Paul C Reilly | director | 880 CARILLON PARKWAY, ST. PETERSBURG FL 33716 |
Alexis Faber | officer: Chief Operating Officer | 3340 PLAYERS CLUB PARKWAY, SUITE 200, MEMPHIS TN 38125 |
Andrew Jay Krasner | officer: Chief Financial Officer | 1450 BRICKELL AVENUE, SUITE 1600, MIAMI FL 33131 |
Fumbi F. Chima | director | 44 THORNBURY CT., 36-38 CHEPSTOW VILLAS, LONDON X0 WII 2RE |
Michelle R Swanback | director | 7001 EAST BELLEVIEW AVENUE, DENVER CO 80237 |
Inga K Beale | director | C/O CRAWFORD & COMPANY, 5335 TRIANGLE PARKWAY, PEACHTREE CORNERS GA 30092 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.